Grifols Sa Adr Stock Performance
| GIKLY Stock | USD 5.56 0.56 11.20% |
On a scale of 0 to 100, Grifols SA holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of -1.2, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Grifols SA are expected to decrease by larger amounts. On the other hand, during market turmoil, Grifols SA is expected to outperform it. Please check Grifols SA's sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Grifols SA's current trending patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Grifols SA ADR are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Grifols SA showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 579.6 M | |
| Total Cashflows From Investing Activities | -29.4 M |
Grifols |
Grifols SA Relative Risk vs. Return Landscape
If you would invest 487.00 in Grifols SA ADR on July 5, 2024 and sell it today you would earn a total of 69.00 from holding Grifols SA ADR or generate 14.17% return on investment over 90 days. Grifols SA ADR is currently producing 0.2771% returns and takes up 3.7728% volatility of returns over 90 trading days. Put another way, 33% of traded pink sheets are less volatile than Grifols, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Grifols SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grifols SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Grifols SA ADR, and traders can use it to determine the average amount a Grifols SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0734
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GIKLY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.77 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Grifols SA is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grifols SA by adding it to a well-diversified portfolio.
Grifols SA Fundamentals Growth
Grifols Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Grifols SA, and Grifols SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Grifols Pink Sheet performance.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 16.07 B | |||
| Shares Outstanding | 1.36 B | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.03 X | |||
| Price To Sales | 1.47 X | |||
| Revenue | 4.93 B | |||
| EBITDA | 861.51 M | |||
| Cash And Equivalents | 549.09 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 6.1 B | |||
| Debt To Equity | 1.14 % | |||
| Book Value Per Share | 4.66 X | |||
| Cash Flow From Operations | 596.98 M | |||
| Earnings Per Share | 0.05 X | |||
| Total Asset | 19.23 B | |||
| Retained Earnings | 468 M | |||
| Current Asset | 2.95 B | |||
| Current Liabilities | 926 M | |||
About Grifols SA Performance
Evaluating Grifols SA's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Grifols SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Grifols SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 27584 people.Things to note about Grifols SA ADR performance evaluation
Checking the ongoing alerts about Grifols SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Grifols SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Grifols SA ADR had very high historical volatility over the last 90 days |
- Analyzing Grifols SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Grifols SA's stock is overvalued or undervalued compared to its peers.
- Examining Grifols SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Grifols SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Grifols SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Grifols SA's pink sheet. These opinions can provide insight into Grifols SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Grifols Pink Sheet Analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.